Korea Post Marketing Surveillance (PMS) Study of Talzenna®

Clinical trial NCT04982848 · NOT_YET_RECRUITING

Trial details

NCT number: NCT04982848
Sponsor: Pfizer
Status: NOT_YET_RECRUITING
Study type: OBSERVATIONAL

Breast Neoplasms

Start date: 2027-06-01
Primary completion: 2028-11-01
Enrollment: 600

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.